What it is
A synthetic analog of the first 29 amino acids of growth hormone-releasing hormone (GHRH), without the drug affinity complex (DAC). Supplied as a lyophilized powder.
How it works
Binds the GHRH receptor on pituitary somatotrophs, stimulating short pulses of growth hormone release. Lacks the DAC modification that extends half-life.
Where it's used
Studied in research settings as a short-acting GHRH analog.
Regulatory status
Not FDA-approved; research compound.
Reconstitution
Supplied as a lyophilized powder requiring reconstitution with bacteriostatic water prior to use.
Tracking it
CJC-1295 is injectable, so two things matter in a log: when you dosed and where. Rotating sites and writing both down prevents the classic “did I already pin the left side?” problem. with a half-life of about 30 minutes, a dose log also lets a tracker model the relative amount still in your system between doses.
Source
Public reference
Last reviewed 2026-06-11